The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage chemical process. Early routes focused on protein fragment coupling, utilizing solid-phase https://keithtatm420381.jaiblogs.com/67750317/synthesis-and-investigation-uses-of-retatrutide